Congressional Briefing: Realizing the Promise of Gene Therapy through Science & Policy
On February 21, the Institute for Gene Therapies hosted a panel discussion on the science of gene therapy, its impact on patients and...
Congressional Briefing: Realizing the Promise of Gene Therapy through Science & Policy
ICYMI: Cure Sickle Cell Disease by 2030?
A Bold Goal to Cure Sickle Cell Disease by 2030
IGT Comments on CMS Fiscal Year 2023 Medicare Inpatient Prospective Payment Systems Proposed Rule
New Resource: Understanding the Complexity of Gene Therapy Science & Manufacturing
IGT Chairman Erik Paulsen Joins Healthy Future Task Force Treatments Subcommittee Roundtable
A Troubling Policy Proposal
Prioritizing Minority Health
IGT Statement on the Introduction of the Medicaid VBPs for Patients Act (H.R. 7389)
Rare Disease Day Spotlight: Hope for HPP Patients